Adolescent and Young Adult Cancer Survivors: Identity Development - Full Text View

Sponsored by:	Memorial Sloan-Kettering Cancer Center
Information provided by:	Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:	NCT00832325

Purpose

The purpose of this study is to better understand how the illness has affected the identity and what needs the survivor may have. We hope that this information will help us provide better care to future adolescent and young adult cancer survivors.

Condition	Intervention
Cancer	Behavioral: interview Behavioral: Focus groups Behavioral: Questionnaire

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Adolescent and Young Adult Cancer Survivors: Identity Development

Resource links provided by NLM:

MedlinePlus related topics: Cancer

U.S. FDA Resources

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:

Conduct a comprehensive qualitative assessment through individual interviews and focus groups of identity development, peer and family relationships, and psychosocial concerns among survivors diagnosed during adolescence. [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Conduct a prospective longitudinal assessment of identity development and peer and family relationships among survivors diagnosed during adolescence. [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	300
Study Start Date:	January 2009
Estimated Study Completion Date:	January 2012
Estimated Primary Completion Date:	January 2012 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1 individual interviews The patient will be asked to come in to the Counseling Center at MSKCC (641 Lexington Avenue, 7th Floor) and participate in an individual interview at their convenience.	Behavioral: interview The doctor and/or one of her trained research study staff will ask the patient about their experience as an adolescent/young adult cancer survivor, their health and quality of life. It should take (approximately 1-1 ½ hours)to complete. Interviews will be audiotaped and transcribed by a professional transcription service.
2 Focus Groups The patient will be asked to come in to the Counseling Center at MSKCC (641 Lexington Avenue, 7th Floor) and participate in a focus group at their convenience.	Behavioral: Focus groups The patient will participate with 6-8 other adolescent/young adult cancer survivors. The doctor and/or her trained research study staff will ask about their experience as an adolescent/young adult cancer survivor, their health and quality of life. It should take about one-and-a-half hour to complete. Focus groups will be audio taped and transcribed by a professional transcription service.
3 Questionnaire The patient will be asked to participate in three 60-90 minute telephone interviews scheduled at their convenience.	Behavioral: Questionnaire The patient will be asked to participate in three 60-90 minute telephone interviews conducted by the doctor and/or her trained research study staff scheduled at the patient's convenience, about 8-10 months apart. The questionnaire will ask about their experience as an adolescent/young adult cancer survivor, their health and quality of life.

Eligibility

Ages Eligible for Study:	15 Years to 24 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

adolescent survivors from MSKCC

Criteria

Inclusion Criteria:

Current age greater than and including 15 and up to and including 24 years of age
Diagnosis of a first cancer > or = to 14 and up to and including 20 years of age
At least 6 months post-treatment
Not currently undergoing active cancer treatment
Able to provide informed consent (or parent or legal guardian consent and participant assent for those participants under 18 years of age)
Able to speak English. This inclusion criterion is included because study assessments were designed and validated in English and many of them are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the assessments.

Exclusion Criteria:

Will exclude survivors with severe cognitive impairment that precludes them from being able to give information consent and/or complete the questionnaires.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00832325

Contacts

Contact: Jennifer Ford, PhD	646-888-0042
Contact: Charles Sklar, MD	212-639-8138

Locations

United States, New York
Memorial Sloan-Kettering Cancer Center	Recruiting
New York, New York, United States, 10065
Contact: Jennifer Ford, PhD 646-888-0042

Sponsors and Collaborators

Memorial Sloan-Kettering Cancer Center

Investigators

Principal Investigator:

Jennifer Ford, PhD

Memorial Sloan-Kettering Cancer Center

More Information

Additional Information:

Memorial Sloan-Kettering Cancer Center This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party:	Memorial Sloan-Kettering Cancer Center ( Jennifer Ford, PhD )
Study ID Numbers:	09-001
Study First Received:	January 28, 2009
Last Updated:	August 14, 2009
ClinicalTrials.gov Identifier:	NCT00832325 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:

Childhood Survivor
survivors
Young Adult Cancer Survivors
Childhood cancers

ClinicalTrials.gov processed this record on August 28, 2009